Free Trial

XTX Topco Ltd Has $246,000 Stock Holdings in Chemed Corporation (NYSE:CHE)

Chemed logo with Medical background

Key Points

  • XTX Topco Ltd significantly reduced its position in Chemed Corporation by 92.4%, ending with 400 shares valued at $246,000 after selling 4,881 shares.
  • Chemed recently missed earnings expectations, reporting $4.27 EPS against a consensus estimate of $6.02, with revenues of $618.80 million compared to an expected $650.60 million.
  • The company has announced an increase in its quarterly dividend from $0.50 to $0.60 per share, reflecting a boost in its annualized dividend yield to 0.6%.
  • MarketBeat previews the top five stocks to own by October 1st.

XTX Topco Ltd reduced its holdings in Chemed Corporation (NYSE:CHE - Free Report) by 92.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 400 shares of the company's stock after selling 4,881 shares during the quarter. XTX Topco Ltd's holdings in Chemed were worth $246,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management acquired a new stake in Chemed in the 1st quarter valued at approximately $29,000. HM Payson & Co. acquired a new position in shares of Chemed during the 1st quarter valued at $30,000. Whipplewood Advisors LLC increased its position in shares of Chemed by 54.5% during the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after purchasing an additional 18 shares during the period. Versant Capital Management Inc increased its position in shares of Chemed by 600.0% during the 1st quarter. Versant Capital Management Inc now owns 98 shares of the company's stock valued at $60,000 after purchasing an additional 84 shares during the period. Finally, Farther Finance Advisors LLC increased its position in shares of Chemed by 23.0% during the 1st quarter. Farther Finance Advisors LLC now owns 150 shares of the company's stock valued at $93,000 after purchasing an additional 28 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CHE shares. Jefferies Financial Group started coverage on Chemed in a research report on Friday, July 25th. They set a "hold" rating and a $500.00 price target on the stock. Wall Street Zen cut Chemed from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Bank of America lowered their price target on Chemed from $708.00 to $650.00 and set a "buy" rating on the stock in a research report on Monday, June 30th. Oppenheimer lowered their price target on Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Finally, Royal Bank Of Canada lowered their price target on Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $579.75.

Check Out Our Latest Stock Analysis on CHE

Chemed Trading Up 0.3%

Shares of NYSE CHE traded up $1.13 during mid-day trading on Friday, reaching $445.00. The company had a trading volume of 177,141 shares, compared to its average volume of 192,563. The stock has a market cap of $6.48 billion, a PE ratio of 22.88, a P/E/G ratio of 2.45 and a beta of 0.46. The company has a 50-day moving average price of $482.43 and a two-hundred day moving average price of $544.44. Chemed Corporation has a 1-year low of $408.42 and a 1-year high of $623.60.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). The company had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%. The business's revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.47 earnings per share. On average, research analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Monday, August 11th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, August 11th. This is a positive change from Chemed's previous quarterly dividend of $0.50. Chemed's payout ratio is presently 12.34%.

Insiders Place Their Bets

In other Chemed news, Director George J. Walsh III bought 200 shares of the firm's stock in a transaction dated Monday, August 4th. The stock was acquired at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the transaction, the director directly owned 3,523 shares in the company, valued at approximately $1,469,443.30. This represents a 6.02% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the firm's stock in a transaction on Monday, August 4th. The stock was sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. Insiders own 3.29% of the company's stock.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines